Anticancer activity of tetrandrine tetrandrine by inducing pro‐death apoptosis and autophagy in human gastric cancer cells

摘要

Abstract Objectives To investigate the antitumour property of tetrandrine by inducing autophagy and apoptosis in human gastric cancer cells, and to explore the potential molecular mechanisms. Methods The antitumour activity of tetrandrine was assessed through MTT assay. Apoptosis was measured by flow cytometry and microscopic examination of cellular morphology. The mitochondrial membrane potential was detected by staining with Rh‐123. Induction of autophagy was monitored by transmission electron microscopy observation, using GFP ‐ LC 3 transfection. Key findings The results revealed that tetrandrine exhibits significant antitumour activity against gastric human cancer cell and the antigastric tumour activity was depended on inducing autophagy and apoptosis through upregulating the apoptosis‐related protein (cleaved PARP , cleaved caspase‐3 and cleaved caspase‐9) and autophagy‐related protein (Beclin‐1, LC 3‐ II and p62), and decreasing the phosphorylation of AKT / mTOR , PS 6K and P‐4 EBP 1. Adding the inhibitor of autophagy, 3‐ MA or Baf‐A1, increased the viability of tetrandrine ‐exposed gastric cancer cells, which confirmed the role of autophagy played in the gastric cancer cell death induced by tetrandrine . Conclusions These results demonstrated that the antitumour effects of tetrandrine by inducing autophagy and apoptosis involving Akt/ mTOR pathway. Thus, tetrandrine may be a promising lead compound to be further developed in future for cancer therapy.